AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23696633
Drug: Infliximab (IFX)
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab (IFX) plus naproxen (NPX) 1000 mg daily
Trial: 23696633
Drug: Placebo (PBO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PBO) plus naproxen (NPX) 1000 mg daily
Trial: 15277618
Drug: frovatriptan 2.5
RxNorm normalized name: frovatriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: frovatriptan 2.5 mg QD
Trial: 10945314
Drug: Methoxsalen 10
RxNorm normalized name: methoxsalen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methoxsalen 10 mg plus nicotine 4 mg
Trial: 10945314
Drug: Methoxsalen 30
RxNorm normalized name: Methoxsalen
DrugBank: Methoxsalen (DB00553)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methoxsalen 30 mg plus nicotine 4 mg
Trial: 10945314
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus nicotine 4 mg
Trial: 29443653
Drug: No Chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Chemotherapy (no CT)
Trial: 24887252
Drug: Caudal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal bupivacaine 0.25% at 1 ml/kg and neostigmine 1.5 ug/kg
Trial: 24887252
Drug: Caudal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal bupivacaine 0.25% at 1 ml/kg
Trial: 20378840
Drug: 28 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 28 g/day textured soy flour (containing 14 g of soy protein) for 8 weeks
Trial: 15703206
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate (375 mg/day, titrated up to 2250 mg)
Trial: 8942593
Drug: Intramuscular tenoxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular tenoxicam 7.5 mg (IM group)
Trial: 1822480
Drug: Nursing intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nursing intervention program including four 1 1/2 hour classes held at weekly intervals, selected maternal‐fetal interactive activities, recording of fetal movements, and maintaining of maternal diaries
Trial: 24407163
Drug: Broad keywords
RxNorm normalized name: broad leaved paperbark pollen extract
DrugBank: Melaleuca quinquenervia pollen (DB10478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broad keywords (e.g., pregnancy)
Trial: 11783602
Drug: Control of
RxNorm normalized name: A replication-competent adenovirus type 5 in which the E1A and E1B genes are under the control of a human telomerase reverse transcriptase (hTERT) and IRES, respectively.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control of blood pressure using ACE inhibitors, beta blockers, calcium antagonists, and/or thiazides.
Trial: 9408691
Drug: Urodilatin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urodilatin at a dose of 20 ng/kg/min for 7 days
Trial: 14612478
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion for 7 days
Trial: 3595071
Drug: Anirolac, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anirolac, 100 mg
Trial: 3595071
Drug: Anirolac, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anirolac, 50 mg
Trial: 3595071
Drug: Naproxen, 550
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen, 550 mg
Trial: 3595071
Drug: All active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All active agents (Anirolac 50 mg, Anirolac 100 mg, Naproxen 550 mg)
Trial: 31629852
Drug: CoQ10 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoQ10 (400 mg per day)
Trial: 23890931
Drug: Diuretic (hydrochlorothiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic (hydrochlorothiazide 25 mg)
Trial: 23890931
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, or calcium channel blocker
Trial: 23890931
Drug: Uncontrolled RH
RxNorm normalized name: anti-D (rh) immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uncontrolled RH treatment
Trial: 21940597
Drug: HAMSB40 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAMSB40 (40 g cooked high‐amylose maize starch with 31.8 mmol esterified butyrate)
Trial: 21940597
Drug: HAMSB20 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAMSB20 (20 g cooked high‐amylose maize starch with 31.8 mmol esterified butyrate)
Trial: 30074128
Drug: Prasugrel 3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 3.75 mg/day
Trial: 31769845
Drug: Enteric-coated Mycophenolate
RxNorm normalized name: mycophenolic acid
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteric-coated Mycophenolate Sodium (EC-MPS) plus low-dose prednisolone (0.25 mg/kg/day)
Trial: 31769845
Drug: Standard-dose prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose prednisolone (1 mg/kg/day)
Trial: 23211356
Drug: Continued dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued dual antiplatelet therapy (DAPT)
Trial: 23211356
Drug: No continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No continued dual antiplatelet therapy (DAPT)
Trial: 19403844
Drug: Positive estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive estrogen receptor status
Trial: 9303286
Drug: Subcutaneous ring
RxNorm normalized name: RING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous ring block
Trial: 8367976
Drug: sustained‐release bezafibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sustained‐release bezafibrate 400 mg daily (n = 21)
Trial: 3788835
Drug: Oral-calcium supplementation
RxNorm normalized name: biotin / dicalcium phosphate Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-calcium supplementation (1500 mg Ca++/day for 6 wk)
Trial: 30227772
Drug: Drug-eluting balloon
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting balloon
Trial: 22422777
Drug: GnRH-agonist (intranasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH-agonist (intranasal buserelin 600 mg per day starting on Day 21 of the preceding cycle)
Trial: 22422777
Drug: GnRH-agonist (progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH-agonist (progesterone >1.5 ng/ml)
Trial: 22422777
Drug: GnRH-antagonist (progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH-antagonist (progesterone >1.5 ng/ml)
Trial: 16277137
Drug: Cognitive‐Behavioural Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐Behavioural Therapy (CBT) alone
Trial: 16277137
Drug: SSRI antidepressant
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSRI antidepressant therapy (fluoxetine) alone
Trial: 16277137
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBT plus fluoxetine
Trial: 2652027
Drug: Povidone-iodine 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Povidone-iodine 5% solution for 3 days before surgery
Trial: 1183355
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg digoxin
Trial: 19169265
Drug: D-004 (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-004 (320 mg) capsules administered daily for 6 weeks
Trial: 10393475
Drug: Doxazosin (1-16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (1-16 mg)
Trial: 8938652
Drug: Doxazosin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (1 mg)
Trial: 10393475
Drug: Terazosin (1-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (1-2 mg)
Trial: 6341944
Drug: Haemophilus influenzae
RxNorm normalized name: HAEMOPHILUS INFLUENZAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haemophilus influenzae type b (Hib) capsular polysaccharide vaccine
Trial: 27562219
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg ibuprofen 1 hour before surgery and another 600 mg 6 hours after the first dose
Trial: 27562219
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg dexamethasone 1 hour before surgery and another 4 mg 6 hours after the first dose
Trial: 15718316
Drug: Iridium implant
RxNorm normalized name: iridium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iridium implant (IM) plus external-beam radiation therapy (EBRT)
Trial: 9655717
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg budesonide twice daily
Trial: 9655717
Drug: 100 microg
RxNorm normalized name: Digoxin 100 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 microg budesonide twice daily
Trial: 7640129
Drug: Amethocaine gel
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amethocaine gel 1 g (4% w/w)
Trial: 7640129
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel 1 g
Trial: 2671191
Drug: Biological mitral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological mitral valves
Trial: 25650733
Drug: Following the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Following the American College of Sports Medicine physical activity guidelines for body weight loss with 25-30% caloric restriction
Trial: 24930512
Drug: Nebulized methacholine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized methacholine inhalation (0.39 to 25 mg/ml)
Trial: 23071344
Drug: Massage intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage intervention (weekly 45-minute massages for 4 weeks)
Trial: 17589833
Drug: Venlafaxine ER
RxNorm normalized name: Venlafaxine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine ER 75 mg
Trial: 27254743
Drug: Calcium (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1200 mg daily)
Trial: 28619696
Drug: Multimodal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal analgesia (mainly antipyretic analgesics, nonsteroidal anti-inflammatory drugs, opioids)
Trial: 28619696
Drug: Acute opioid
RxNorm normalized name: OPIOIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute opioid treatments
Trial: 28619696
Drug: Patient-controlled analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled analgesia (intravenous morphine)
Trial: 25759961
Drug: Oral zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zinc supplementation (10 mg Zn/day) and venous zinc administration (0.06537 mg Zn/kg of body weight) in the experimental group.
Trial: 21042875
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (N = 40; 1.8 g/day, EPA + DHA = 864 mg)
Trial: 17550932
Drug: Aminoguanidine (iNOS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminoguanidine (iNOS inhibitor)
Trial: 9354206
Drug: Oral benzocaine
RxNorm normalized name: benzocaine Oral Paste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral benzocaine 0.75% solution (n = 14)
Trial: 20831528
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 5 mg/kg/h for 6 hours for 6 successive days
Trial: 15867559
Drug: C-labeled nandrolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-labeled nandrolone (25 mg dose, followed by a second identical dose 24 hours later)
Trial: 28121172
Drug: Cardiac rehabilitation
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac rehabilitation consisting of 12 weeks of physical exercise training and monthly psycho-educational consultations
Trial: 19671410
Drug: Shengmai (SM)
RxNorm normalized name: Samarium Sm-153
DrugBank: Samarium Sm-153 (DB12905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shengmai (SM) Capsule
Trial: 17077230
Drug: Standard access
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard access to emergency contraceptive pills (pills dispensed when needed at usual charges)
Trial: 17077230
Drug: Increased access
RxNorm normalized name: sofosbuvir
DrugBank: Sofosbuvir (DB08934)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Increased access to emergency contraceptive pills
Trial: 11531217
Drug: Choline-supplemented TPN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline-supplemented TPN (2 g choline chloride added)
Trial: 3069751
Drug: Two tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two tablets of 100 mg ibopamine (SIMES formulations)
Trial: 24584382
Drug: Mebeverine 135mg
RxNorm normalized name: mebeverine
DrugBank: Mebeverine (DB12554)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebeverine 135mg twice daily
Trial: 18450862
Drug: European Bladder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: European Bladder Dysfunction Study treatment
Trial: 8718542
Drug: Calcium lactate
RxNorm normalized name: Calcium Lactate
DrugBank: Calcium lactate (DB13231)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium lactate (Ca) 2 g/day (Group-Ca)
Trial: 1400926
Drug: Sequential combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential combination of oestradiol valerate (2 mg, days 1-28) and levonorgestrel (75 micrograms, days 17-28)
Trial: 1400926
Drug: Continuous combination
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous combination of oestradiol valerate (2 mg, days 1-28) and cyproterone acetate (1 mg, days 1-28)
Trial: 2935765
Drug: 1% etidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% etidocaine 5 mL dropped on each fallopian tube before tubal banding
Trial: 2935765
Drug: No topical
RxNorm normalized name: Altreno Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No topical anesthetic agent
Trial: 2935765
Drug: 1% etidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% etidocaine 5 mL
Trial: 22796902
Drug: Polyphenol-rich dark
RxNorm normalized name: dark leaved mugwort pollen extract
DrugBank: Artemisia ludoviciana pollen (DB10762)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyphenol-rich dark chocolate (DC) 20 g containing 500 mg polyphenols
Trial: 17088909
Drug: Cumulative anthracycline
RxNorm normalized name: methacycline
DrugBank: Metacycline (DB00931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cumulative anthracycline dose
Trial: 8831364
Drug: Verapamil (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (0.15 mg/kg)
Trial: 25130503
Drug: Cluster immunotherapy
RxNorm normalized name: cluster fig extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cluster immunotherapy with high polymerized allergen extract of grass/rye pollen mixture
Trial: 19967558
Drug: Letrozole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (2.5 mg daily)
Trial: 18696285
Drug: Clonidine adhesive
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine adhesive patch (1.0mg, 1.5mg, or 2.0mg per week for 4 weeks)
Trial: 18696285
Drug: Placebo adhesive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo adhesive patch
Trial: 9613269
Drug: Vecuronium 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.2 mg.kg‐1
Trial: 8598261
Drug: Polyethylene glycol
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol (PEG) at low dosage
Trial: 22743160
Drug: Drug Counseling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Counseling (DC)
Trial: 18751444
Drug: Paclitaxel (PTX)
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel (PTX) 80 mg/m2 weekly
Trial: 18751444
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin (PLD) 12.5 mg/m2 every two weeks
Trial: 18751444
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PTX and PLD
Trial: 12873918
Drug: 1 micro
RxNorm normalized name: SAIF 1 Micro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 micro g/kg IV fentanyl 10 min before discontinuation of anesthetic
Trial: 11783029
Drug: Carboplatin solution
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin solution (injection group)
Trial: 29126686
Drug: RBC transfusion
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC transfusion threshold of Hb 80 g/L
Trial: 29126686
Drug: RBC transfusion
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC transfusion threshold of Hb 100 g/L
Trial: 24606873
Drug: Cognitive Behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behaviour Therapy for Anorexia Nervosa (CBT-AN)
Trial: 11550961
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg doxycycline twice a day
Trial: 7933707
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (200 or 400 mg)
Trial: 3284491
Drug: Glucose-containing priming
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-containing priming solutions
Trial: 1106289
Drug: Same treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Same treatment by private physician.
Trial: 28917226
Drug: Average daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Average daily energy intake <50% of requirement (Group A)
Trial: 28917226
Drug: Average daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Average daily energy intake >=50% of requirement (Group B)
Trial: 25776489
Drug: Catheter administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Catheter administration of bupivacaine in female patients
Trial: 19954717
Drug: Thrombo (EIPICO,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombo (EIPICO, Egypt) 75 mg tablets
Trial: 16765700
Drug: timolol‐pilocarpine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: timolol‐pilocarpine combination
Trial: 7064850
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg)
Trial: 3222686
Drug: (+/-)-nicardipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (+/-)-nicardipine (20 mg)
Trial: 15575343
Drug: Orlistat (360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat (360 mg/d)
Trial: 9782075
Drug: 135 mg
RxNorm normalized name: cocaine 135 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 135 mg m-2 paclitaxel administered by 3-hour infusion
Trial: 7929727
Drug: Conservative management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative management with hospitalization, intravenous hydration, and supportive therapy.
Trial: 23425051
Drug: Local steroid
RxNorm normalized name: RECTAL,LOCAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local steroid injection and balloon dilatation
Trial: 23425051
Drug: Steroid application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid application and balloon dilatation
Trial: 18832295
Drug: Vildagliptin 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 25 to 200 mg qd
Trial: 18832295
Drug: Vildagliptin 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 200 mg qd
Trial: 15631798
Drug: Cefoperazone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone plus sulbactam (sulperazon) (2 g i.v. before and after surgery)
Trial: 11052511
Drug: 2 percent
RxNorm normalized name: ALCOHOL 62 mL in 100 mL TOPICAL GEL [The Keeps ETHANOL 62 percent]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 percent diltiazem gel
Trial: 1524960
Drug: pH-feedback controlled
RxNorm normalized name: PH-284
DrugBank: PH-284 (DB05452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pH-feedback controlled infusion of ranitidine
Trial: 1524960
Drug: fixed-rate infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: fixed-rate infusion of ranitidine
Trial: 1524960
Drug: fixed-dose infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: fixed-dose infusion of ranitidine
Trial: 30281086
Drug: CBT2go (cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBT2go (cognitive behavioral therapy combined with automated thought challenging/adaptive behavior)
Trial: 20932581
Drug: Baerveldt glaucoma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baerveldt glaucoma implant (BGI; model 101-350)
Trial: 15074089
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of human chorionic gonadotropine (hCG)
Trial: 9720158
Drug: Intraoperative bleeding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative bleeding from aneurysms of the ophthalmic segment of ICA (19 cases)
Trial: 12030915
Drug: 2.5% testosterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% testosterone gel preparation
Trial: 1103113
Drug: Feprazone 450
RxNorm normalized name: feprazone
DrugBank: Feprazone (DB13364)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feprazone 450 mg daily